Immix Biopharma Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +114.5% | +6.3% | -13.5% | +156.1% | +2,010.2% | +215.9% | |
| – | – | – | +185.0% | +311.1% | +17.7% | -19.2% | |
| – | +0.0% | +3,921.7% | -97.3% | – | – | – | |
| – | -8.7% | -335.8% | – | +746.8% | +140.0% | -31.9% | |
| – | -99.9% | +19,950.0% | -99.6% | +1,736,200.0% | +2,160.9% | -37.8% | |
| – | -89.0% | +0.0% | – | – | +2,160.9% | +512.5% | |
| – | – | – | – | -56.0% | – | – | |
| – | -81.0% | +0.0% | -125.0% | -100.0% | – | – | |
| – | +1,695.1% | +0.0% | -82.9% | +378.4% | +3.1% | +573.3% | |
| – | -226.2% | – | -124.4% | – | -95.8% | +44,187.5% | |
| – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.